These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 37608332

  • 21. A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa.
    Silumbwe A, Zulu JM, Halwindi H, Jacobs C, Zgambo J, Dambe R, Chola M, Chongwe G, Michelo C.
    BMC Public Health; 2017 May 22; 17(1):484. PubMed ID: 28532397
    [Abstract] [Full Text] [Related]

  • 22. Gender-related factors affecting health seeking for neglected tropical diseases: findings from a qualitative study in Ethiopia.
    Wharton-Smith A, Rassi C, Batisso E, Ortu G, King R, Endriyas M, Counihan H, Hamade P, Getachew D.
    PLoS Negl Trop Dis; 2019 Dec 22; 13(12):e0007840. PubMed ID: 31830026
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S, Toothong T, Boondej P, Thammapalo S, Khuanyoung N, Santabutr W, Prempree P, Gopinath D, Ramaiah KD.
    Infect Dis Poverty; 2019 May 27; 8(1):38. PubMed ID: 31130143
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Unlocking Trust in Community Health Systems: Lessons From the Lymphatic Filariasis Morbidity Management and Disability Prevention Pilot Project in Luangwa District, Zambia.
    Zulu JM, Maritim P, Silumbwe A, Halwiindi H, Mubita P, Sichone G, Mpandamabula CH, Shamilimo F, Michelo C.
    Int J Health Policy Manag; 2022 Jan 01; 11(1):80-89. PubMed ID: 34814671
    [Abstract] [Full Text] [Related]

  • 30. Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.
    Sabesan S, Krishnamoorthy K, Hoti SL, Subramanian S, Srividya A, Roy N, Jain T, Kumar A, Rahi M.
    Indian J Med Res; 2022 Mar 01; 155(3&4):347-355. PubMed ID: 36124509
    [Abstract] [Full Text] [Related]

  • 31. Ethnicity, gender, and migration status: Applying intersectionality methodology to explore barriers to equitable health systems for maternal and newborn health among immigrant populations in Masindi, Uganda.
    Mangwi Ayiasi R, Ochola Mangwi AJ, Young R, Garimoi Orach C, Morgan R.
    Medicine (Baltimore); 2022 Jul 29; 101(30):e29698. PubMed ID: 35905205
    [Abstract] [Full Text] [Related]

  • 32. Lymphatic filariasis and the women of India.
    Bandyopadhyay L.
    Soc Sci Med; 1996 May 29; 42(10):1401-10. PubMed ID: 8735896
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Status of lymphatic filariasis with progression of age and gender & eradication strategies: A survey among residents of Hardoi district of Uttar Pradesh, an endemic region of North India.
    Saeed M, Faisal SM, Ahmad I, Kausar MA, Alam MJ, Khan S, Mustafa H.
    Cell Mol Biol (Noisy-le-grand); 2018 Mar 31; 64(4):46-51. PubMed ID: 29642988
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya.
    Njenga SM, Kanyi HM, Mutungi FM, Okoyo C, Matendechero HS, Pullan RL, Halliday KE, Brooker SJ, Wamae CN, Onsongo JK, Won KY.
    Parasit Vectors; 2017 Feb 22; 10(1):99. PubMed ID: 28228160
    [Abstract] [Full Text] [Related]

  • 37. Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis.
    Krentel A, Gyapong M, McFarland DA, Ogundahunsi O, Titaley CR, Addiss DG.
    Int Health; 2020 Dec 22; 13(Supplement_1):S55-S59. PubMed ID: 33349882
    [Abstract] [Full Text] [Related]

  • 38. Information technology in morbidity management of human lymphatic filariasis-A promising tool in global programme for elimination of lymphatic filariasis.
    Devi RR, Raju V.
    J Vector Borne Dis; 2018 Dec 22; 55(1):20-25. PubMed ID: 29916444
    [Abstract] [Full Text] [Related]

  • 39. Lessons from the Pacific programme to eliminate lymphatic filariasis: a case study of 5 countries.
    Huppatz C, Capuano C, Palmer K, Kelly PM, Durrheim DN.
    BMC Infect Dis; 2009 Jun 12; 9():92. PubMed ID: 19523192
    [Abstract] [Full Text] [Related]

  • 40. Community and Drug Distributor Perceptions and Experiences of Mass Drug Administration for the Elimination of Lymphatic Filariasis: A Rapid Review of Qualitative Research.
    Ames HMR, Zuske M, King JD, Steinmann P, Bosch-Capblanch X.
    Adv Parasitol; 2019 Jun 12; 103():117-149. PubMed ID: 30878056
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.